Funding for this research was provided by:
National Natural Science Foundation of China (81973154, 81502897)
Received: 27 April 2021
Accepted: 8 August 2021
First Online: 13 August 2021
: This study was approved by the Shan Xi Tumor Hospital Ethics Committee and obtained the reference number of 201835. All participants were informed and agreed to the study. We obtained the informed with oral consent form each participant. All research process was approved by the ethics committee, and all methods carried out in accordance with relevant guidelines and regulations in ethics.
: Not applicable.
: The authors declare that they have no competing interests.